Research Update Postcard From Palm Springs
Charles Sabine, International HD advocate brings us video highlights from CHDI's Annual 2020 Huntington's Disease Therapeutic Conference.
'There are multiple companies approaching multiple ways of lowering mutant huntington' Ignacio Munoz Sanjuan, Vice President, Translational Biology, CHDI
'Ours is a terrible disease but there's never been a more hopeful time' Charles Sabine
Professor Sarah Tabrizi discusses the benefits of Enroll-HD and other observational studies which help scientists learn more about the disease. 'The more we understand the premanifest phase of the disease the more we will be able to intervene at an early stage to slow or prevent the disease.'